Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
637.55
14.75 (2.37%)
BSENSE

Mar 25

BSE+NSE Vol: 2.49 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
432.27
418.33
386.19
563.78
537.78
458.03
555.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
432.27
418.33
386.19
563.78
537.78
458.03
555.49
Raw Material Cost
209.42
203.46
191.42
185.45
247.30
213.97
208.18
Purchase of Finished goods
2.14
23.26
21.82
-16.27
7.87
98.10
86.94
(Increase) / Decrease In Stocks
-38.90
-16.95
-43.84
109.57
6.25
-83.10
31.50
Employee Cost
43.38
43.41
41.26
43.37
41.63
37.73
39.23
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.01
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
113.92
90.43
80.28
96.03
106.12
97.66
93.19
Total Expenditure (Excl Depreciation)
329.96
343.62
290.95
418.15
409.17
364.36
459.03
Operating Profit (PBDIT) excl Other Income
102.31
74.71
95.24
145.63
128.61
93.67
96.46
Other Income
-0.37
0.05
1.60
-1.61
5.03
4.48
2.22
Operating Profit (PBDIT)
101.94
74.76
96.84
144.02
133.64
98.15
98.68
Interest
12.58
10.67
6.79
6.58
9.97
5.51
4.83
Exceptional Items
-2.79
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
86.57
64.09
90.05
137.44
123.67
92.64
93.85
Depreciation
28.62
24.77
22.79
22.82
23.04
20.88
20.17
Profit Before Tax
62.87
38.69
65.45
114.62
100.63
71.77
73.68
Tax
14.91
10.77
15.95
26.28
26.64
17.15
18.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.04
28.56
51.30
88.34
73.99
54.62
55.45
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.04
28.56
51.30
88.34
73.99
54.62
55.45
Share in Profit of Associates
4.92
-0.64
-1.80
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.96
27.92
49.50
88.34
73.99
54.62
55.45
Equity Capital
45.32
45.32
45.32
45.32
45.31
45.31
45.31
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
5.29
3.08
5.46
9.75
8.16
6.03
6.12
Diluted Earnings per share
5.29
3.08
5.46
9.74
8.16
6.02
6.12
Operating Profit Margin (Excl OI)
23.67%
17.86%
24.66%
25.83%
23.91%
20.45%
17.36%
Gross Profit Margin
20.03%
15.32%
23.32%
24.38%
23.0%
20.23%
16.89%
PAT Margin
11.09%
6.67%
12.82%
15.67%
13.76%
11.92%
9.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.33% vs 8.32% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 71.78% vs -43.60% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 36.94% vs -21.56% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 17.90% vs 57.14% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Aarti Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
432.27
0
432.27
Other Operating Income
0.00
0.00
0.00
Total Operating income
432.27
0
432.27
Raw Material Cost
209.42
0
209.42
Purchase of Finished goods
2.14
0
2.14
(Increase) / Decrease In Stocks
-38.90
0
-38.90
Employee Cost
43.38
0
43.38
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
113.92
0.00
113.92
Total Expenditure (Excl Depreciation)
329.96
0
329.96
Operating Profit (PBDIT) excl Other Income
102.31
0.00
102.31
Other Income
-0.37
0
-0.37
Operating Profit (PBDIT)
101.94
0
101.94
Interest
12.58
0
12.58
Exceptional Items
-2.79
0
-2.79
Gross Profit (PBDT)
86.57
0
86.57
Depreciation
28.62
0
28.62
Profit Before Tax
62.87
0
62.87
Tax
14.91
0
14.91
Provisions and contingencies
0.00
0
0.00
Profit After Tax
43.04
0
43.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
43.04
0
43.04
Share in Profit of Associates
4.92
0
4.92
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.96
0
47.96
Equity Capital
45.32
0
45.32
Face Value
5.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
5.29
0
5.29
Diluted Earnings per share
5.29
0
5.29
Operating Profit Margin (Excl OI)
23.67%
0%
0.00
23.67%
Gross Profit Margin
20.03%
0%
0.00
20.03%
PAT Margin
11.09%
0%
0.00
11.09%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 432.27 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.33% vs 8.32% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -19.62% vs 19.86% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 47.96 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 71.78% vs -43.60% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -35.18% vs 40.24% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 102.31 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 36.94% vs -21.56% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -20.45% vs 34.43% in Dec 2024

Quarterly - Interest
Interest 12.58 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 17.90% vs 57.14% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 26.18% vs 122.54% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.67%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024